Group One Trading’s enGene Therapeutics ENGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$430 Buy
+215
New +$398 ﹤0.01% 7654

Other funds holding ENGN

Group One Trading's ENGN Position: Q3 2026 in Review

Group One Trading opened a new position in enGene Therapeutics (ENGN) in Q3 2026: 215 shares worth $430. The stake represents ﹤0.01% of the portfolio and ranks #7654 among its holdings.

60 funds tracked by Wall St. Rank hold ENGN as of Q3 2026.

  • Group One Trading held 215 shares of enGene Therapeutics worth $430 as of Q3 2026.
  • enGene Therapeutics was a new Group One Trading position in Q3 2026.
  • enGene Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7654 holding.
  • 60 funds tracked by Wall St. Rank held enGene Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.